RxDoctor Payments Data

Sanjeev Puri, MD

Surgery of the Hand · Pasadena, CANPI 1720304447

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Integra Lifesciences Corporation at 27.0% of the total. Reporting peaked in 2023 at $1,145 and has fallen 50.9% since, to $562 in 2025.

$3,541in general payments, 2019–2025

Across 76 payments — averaging $46.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$957
  • TELA Bio, Inc.$558
  • Musculoskeletal Transplant Foundation Inc.$516
  • Aroa Biosurgery Incorporated$178
  • Tactile Systems Technology Inc$145
  • Medtronic$139
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,19590%
  • Other$34610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,541 in reported general payments places this provider in the 60th percentile of 76 surgery of the hand providers in California.

See all surgery of the hand providers in California

Medicare billing

Part B allowed, 2024
$303,930
Medicare patients
204
Services billed
1,934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$3,870
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$250
Pentoxifylline11$244
Cephalexin15$109
Doxycycline Hyclate11$87

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Pasadena

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →